The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Effectiveness of high‐dose riboflavin in migraine prophylaxis A randomized controlled trial
Abstract
A deficit of mitochondrial energy metabolism may play a role in migraine pathogenesis. We found in a previous open study that high-dose riboflavin was effective in migraine prophylaxis. We now compared riboflavin (400 mg) and placebo in 55 patients with migraine in a randomized trial of 3 months duration. Using an intention-to-treat analysis, riboflavin was superior to placebo in reducing attack frequency (p = 0.005) and headache days (p = 0.012). Regarding the latter, the proportion of patients who improved by at least 50%, i.e. "responders," was 15% for placebo and 59% for riboflavin (p = 0.002) and the number-needed-to-treat for effectiveness was 2.3. Three minor adverse events occurred, two in the riboflavin group (diarrhea and polyuria) and one in the placebo group (abdominal cramps). None was serious. Because of its high efficacy, excellent tolerability, and low cost, riboflavin is an interesting option for migraine prophylaxis and a candidate for a comparative trial with an established prophylactic drug.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Anticonvulsant drugs for management of pain: a systematic review
McQuay, H., Carroll, D., Jadad, A. R., Wiffen, P., & Moore, A. (1995) · BMJ · doi:10.1136/bmj.311.7012.1047 · Cited by 713
Peikert, A., Wilimzig, C., & Köhne-Volland, R. (1996) · Cephalalgia · doi:10.1046/j.1468-2982.1996.1604257.x · Cited by 364
Migraine Prophylaxis With Divalproex
Mathew, N. T., Saper, J. R., Silberstein, S. D., Rankin, L., Markley, H. G., Solomon, S., Rapoport, A. M., Silber, C. J., & Deaton, R. L. (1995) · Archives of Neurology · doi:10.1001/archneur.1995.00540270077022 · Cited by 329
Jensen, R., Brinck, T., & Olesen, J. (1994) · Neurology · doi:10.1212/wnl.44.4.647 · Cited by 238
Barbiroli, B., Montagna, P., Cortelli, P., Funicello, R., Iotti, S., Monari, L., Pierangeli, G., Zaniol, P., & Lugaresi, E. (1992) · Neurology · doi:10.1212/wnl.42.6.1209 · Cited by 217
Welch, K. M. A., Levine, S. R., D'Andrea, G., Schultz, L. R., & Helpern, J. A. (1989) · Neurology · doi:10.1212/wnl.39.4.538 · Cited by 205
MELAS syndrome: Characteristic migrainous and epileptic features and maternal transmission
Montagna, P., Gallassi, R., Medori, R., Govoni, E., Zeviani, M., Mauro, S. D., Lugaresi, E., & Andermann, F. (1988) · Neurology · doi:10.1212/wnl.38.5.751 · Cited by 182
MELAS syndrome with mitochondrial tRNA Leu[UUR] mutation
Penn, A. M. W., Lee, J. W. K., Thuillier, P., Wagner, M., Maclure, K. M., Menard, M. R., Hall, L. D., & Kennaway, N. G. (1992) · Neurology · doi:10.1212/wnl.42.11.2147 · Cited by 124
31 P‐Magnetic resonance spectroscopy in migraine without aura
Montagna, P., Cortelli, P., Monari, L., Pierangeli, G., Parchi, P., Lodi, R., Iotti, S., Frassineti, C., Zaniol, P., Lugaresi, E., et al. (1994) · Neurology · doi:10.1212/wnl.44.4.666 · Cited by 123
High-Dose Riboflavin as a Prophylactic Treatment of Migraine: Results of an Open Pilot Study
Schoenen, J. E., Lenaerts, M., & Bastings, E. P. (1994) · Cephalalgia · doi:10.1046/j.1468-2982.1994.1405328.x · Cited by 119
Self-citation
Cited by
Pathophysiology of migraine: a disorder of sensory processing
Goadsby, P. J., Holland, P. R., Martins-Oliveira, M., Hoffmann, J., Schankin, C., & Akerman, S. (2017) · Physiological Reviews · doi:10.1152/physrev.00034.2015 · Cited by 1,998
EFNS guideline on the drug treatment of migraine—revised report of an EFNS task force
Evers, S., Áfra, J., Frese, A., Goadsby, P. J., Linde, M., May, A., & Sándor, P. S. (2009) · European Journal of Neurology · doi:10.1111/j.1468-1331.2009.02748.x · Cited by 892
Berger, M. M., Shenkin, A., Schweinlin, A., Amrein, K., Augsburger, M., Biesalski, H.-K., Bischoff, S. C., Casaer, M. P., Gundogan, K., Lepp, H.-L., et al. (2022) · Clinical Nutrition · doi:10.1016/j.clnu.2022.02.015 · Cited by 615
Silberstein, S. D. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15440-8 · Cited by 420
Efficacy of coenzyme Q10 in migraine prophylaxis: A randomized controlled trial
Sándor, P. S., Di Clemente, L., Coppola, G., Saenger, U., Fumal, A., Magis, D., Seidel, L., Agosti, R. M., & Schoenen, J. (2005) · Neurology · doi:10.1212/01.wnl.0000151975.03598.ed · Cited by 371
Self-citation
Metadata
- Authors
- Schoenen, J., Jacquy, J., & Lenaerts, M.
- Venue
- Neurology
- Published
- 1998-02
- Volume
- 50
- Issue
- 2
- Pages
- 466-470
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W1973157975
- Cited by
- 548
- References
- 17
- FWCI
- 9.93
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effectiveness of high‐dose riboflavin in migraine prophylaxis A randomized controlled trial. https://app.cochat.ai/papers/10.1212/wnl.50.2.466
- The paper
- Schoenen, J., Jacquy, J., & Lenaerts, M. (1998). Effectiveness of high‐dose riboflavin in migraine prophylaxis A randomized controlled trial. Neurology. https://doi.org/10.1212/wnl.50.2.466
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.